Related Experiment Video
Updated: Jul 5, 2025

07:44
Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
Published on: March 12, 2018
10.1K
Exploring the relationship between metabolism and immune microenvironment in osteosarcoma based on metabolic pathways
Changwu Wu1,2, Jun Tan3,4, Hong Shen5,6,7
1Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Journal of Biomedical Science
|January 11, 2024
Summary
Metabolic pathways, particularly vitamin and cofactor metabolism, significantly impact osteosarcoma
Area of Science:
- * Oncology
- * Molecular Biology
- * Immunology
Background:
- * Metabolic reprogramming is crucial in osteosarcoma, influencing prognosis and treatment outcomes.
- * The interplay between tumor metabolism and the tumor immune microenvironment (TIME) in osteosarcoma requires further elucidation.
Purpose of the Study:
- * To investigate the relationship between metabolic pathways and the TIME in osteosarcoma.
- * To identify metabolic features that predict treatment response and patient prognosis.
- * To explore the functional role of key metabolism-related genes in osteosarcoma progression.
Main Methods:
- * Analysis of RNA-Seq and clinical data from TARGET and GEO databases (n=84).
- * Inference of metabolic super-pathway activity and immune cell infiltration.
- * Unsupervised clustering to identify metabolic and metabolism-related gene (MRG) clusters.
- * Construction and validation of an MRG-based risk model.
- * Molecular experiments to assess the function of ST3GAL4 in osteosarcoma cells.
Main Results:
- * Vitamin and cofactor metabolism strongly correlates with osteosarcoma prognosis and TIME.
- * Two distinct metabolic clusters (C1, C2) showed differential immune infiltration and chemotherapeutic response (C2 superior).
- * Three MRG clusters (GC1-3) exhibited distinct prognoses and immune infiltration levels; GC3 predicted better response to immunotherapy and chemotherapy.
- * A validated metabolism-related risk model demonstrated prognostic predictive power, with low-risk groups showing higher immune infiltration.
- * ST3GAL4 knockdown suppressed osteosarcoma cell proliferation, invasion, glycolysis, and M2 macrophage polarization.
Conclusions:
- * Vitamin and cofactor metabolism are key regulators of osteosarcoma TIME and prognosis.
- * MRG clusters effectively reflect TIME alterations and predict responses to chemotherapy and immunotherapy.
- * The developed metabolism-related risk model shows promise for prognostic prediction in osteosarcoma.
- * ST3GAL4 is implicated in osteosarcoma progression, glycolysis, and modulation of the TIME.
Related Concept Videos
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K

